Company Profile

Acaduceus Pharmaceutics Inc
Profile last edited on: 3/4/14      CAGE: 552P4      UEI:

Business Identifier: proprietary molecules in the field of targeted molecular therapeutics, molecular imaging, nanobiotechnology, and stem cells
Year Founded
2008
First Award
2009
Latest Award
2011
Program Status
Inactive
Popularity Index
Is this YOUR Company?
Ensure accuracy and completeness of YOUR Company Profile by completing the brief Survey Instrument attached
Do you know about this Awardees?
Let us encourage you to provide any data which would enhance the completeness of this firm's profile.

Location Information

11171 Bubb Road
Cupertino, CA 95014
   (408) 306-5635
   jennywu@acaduceuspharma.com
   www.acaduceuspharma.com
Location: Single
Congr. District: 18
County: Santa Clara

Public Profile

Acaduceus Pharmaceutics Inc. expedites the development and commercialization of innovative proprietary molecules in the field of targeted molecular therapeutics, molecular imaging, nanobiotechnology, and stem cells with initial applications in the areas of oncologic and cardiovascular molecular medicine. Acaduceus Pharmaceutics Inc. has several molecular imaging and therapy leads in various stages of development.

Extent of SBIR involvement

User Avatar

Synopsis: Awardee Business Condition

Employee Range
1-4
Revenue Range
Less than .5M
VC funded?
No
Public/Private
Privately Held
Stock Info
----
IP Holdings
N/A

Awards Distribution by Agency

Most Recent SBIR Projects

Year Phase Agency Total Amount
2011 1 NIH $236,000
Project Title: Phage Display Peptide Probes For Imaging Early Response To Cancer Therapy
2009 1 NIH $159,988
Project Title: Targeted Prodrug Chemotherapy For Prostate Cancer
2009 1 NIH $100,000
Project Title: Dual Integrin And Grpr Targeted Radiotherapy Of Prostate Cancer

Key People / Management

  Jenny C Wu -- President

Company News

There are no news available.